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Abstract
Introduction
Zambia has made substantial investments in health systems capacity, yet it remains unclear
whether improved service quality improves outcomes. We investigated the association
between health system capacity and use of prevention of mother-to-child HIV transmission
(PMTCT) services in Zambia.
Materials and methods
We analyzed data from two studies conducted in rural and semi-urban Lusaka Province in
2014–2015. Health system capacity, our primary exposure, was measured with a validated
balanced scorecard approach. Based on WHO building blocks for health systems strength-
ening, we derived overall and domain-specific facility scores (range: 0–100), with higher
scores indicating greater capacity. Our outcome, community-level maternal antiretroviral
drug use at 12 months postpartum, was measured via self-report in a large cohort study
evaluating PMTCT program impact. Associations between health systems capacity and our
outcome were analyzed via linear regression.
Results
Among 29 facilities, median overall facility score was 72 (IQR:67–74). Median domain
scores were: patient satisfaction 75 (IQR 71–78); human resources 85 (IQR:63–87); finance
50 (IQR:50–67); governance 82 (IQR:74–91); service capacity 77 (IQR:68–79); service pro-
vision 60 (IQR:52–76). Our programmatic outcome was measured from 804 HIV-infected
mothers. Median community-level antiretroviral use at 12 months was 81% (IQR:69–89%).
Patient satisfaction was the only domain score significantly associated with 12-month mater-
nal antiretroviral use (β:0.22; p = 0.02). When we excluded the human resources and
finance domains, we found a positive association between composite 4-domain facility
score and 12-month maternal antiretroviral use in peri-urban but not rural facilities.
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Conclusions
In these Zambian health facilities, patient satisfaction was positively associated with mater-
nal antiretroviral 12 months postpartum. The association between overall health system
capacity and maternal antiretroviral drug use was stronger in peri-urban versus rural facili-
ties. Additional work is needed to guide strategic investments for improved outcomes in HIV
and broader maternal-child health region-wide.
Background
Over the last decade, tremendous gains have been made in pediatric HIV, largely through the
implementation of effective interventions for the prevention of mother-to-child HIV transmis-
sion (PMTCT)[1]. Strong scientific evidence and forward-thinking policies have led to the
widespread uptake of antiretroviral therapy (ART) by pregnant and breastfeeding women
globally[2, 3]. Increasing coverage of PMTCT programs in priority countries has brought
about a 60% global decline in new pediatric HIV infections since 2010[4], with most countries
reporting significant reductions in mother-to-child HIV transmission and some achieving
near elimination[5, 6].
Although a number of factors may influence access to PMTCT services, the capacity of
health systems to meet demand is critical and may serve as important determinants for uptake,
adherence, and retention[7]. A range of health systems attributes have been associated with
program outcomes, including service coverage and quality, care coordination and support,
and clinical capacity[8–10]. While the World Health Organization (WHO) has emphasized
the need for health system strengthening[11], there remains scarce evidence of how strategic
interventions to improve health system capacity may translate into greater service coverage,
decreased attrition, and improved patient-level outcomes.
In this study, we sought to investigate this possible relationship in the context of PMTCT
services in Zambia’s Lusaka Province. Leveraging data from two parallel, related evaluations,
we focused on a single, important programmatic outcome: maternal antiretroviral use at 12
months following delivery. As PMTCT programs continue to expand globally, there is need to
identify those health systems factors that have greatest impact on health outcomes.
Materials and methods
For this secondary analysis, we used data from two related studies conducted between 2014
and 2015 in rural and semi-urban Lusaka Province, Zambia. Health systems capacity was
assessed through the Better Health Outcomes through Mentoring and Assessment (BHOMA)
initiative, which sought to improve the quality of primary care through community- and facil-
ity-based interventions[12]. Our outcome data were obtained from the community cohort
component of the Survey Validation Project (SUVA), a validation of a household survey meth-
odology for evaluating population-level PMTCT effectiveness. The community cohort served
as the “gold standard” for measuring the primary outcome: HIV-free survival among infants
born to known HIV-infected women[13].
Study setting
The BHOMA and SUVA studies took place across an extensive network of government clinics
and hospitals that comprise essentially all public sector facilities within four of the five districts
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in Lusaka Province, Zambia: Chilanga, Chongwe, Kafue, and Rufunsa. The studies were not
implemented in urban Lusaka District. The combined population of these four districts was
approximately 306,000 at the time of study implementation. Prevalence of HIV among all
adult women in Lusaka Province is 19.4%, while prevalence in the rural and peri-urban areas
is usually slightly lower[14]. At the time of the studies’ implementation, the Zambian Ministry
of Health had recently adopted the WHO-recommended “Option B+” approach of lifelong
ART for all HIV-infected pregnant women, a policy that evolved to become standard of care
[15]. In Zambia, PMTCT programs are typically integrated into maternal-child health services
including postnatal care.
Health systems capacity assessment: The BHOMA study
As part of the BHOMA initiative, three health facility surveys were conducted between 2011
and 2015 to assess changes in health systems capacity. In this analysis, we used data from the
third and final survey, which coincided with enrollment for the SUVA community cohort (see
below). Using a “balanced scorecard” approach[16], we evaluated six domains derived from
the WHO building blocks for health systems strengthening: patient satisfaction, human
resources, finance, governance, service capacity, and service provision[16, 17]. All study tools
were based on direct observation or interviewer-administered questionnaires, except for the
governance assessment which participating stakeholders completed on their own. Depending
on the domain assessed, questionnaires were completed by health facility managers, health
workers or patients.
The patient satisfaction domain comprised adult satisfaction and child satisfaction indices,
which were assessed by exit interviews among five adults and five under-five child/guardian
pairs, respectively[16, 18]. Interviewers asked participants to rate each of the following on a
5-point scale: wait time to be seen by a provider, the provider’s explanation of illness and treat-
ment, and the perceived appropriateness of the treatment received. The human resources
domain was assessed by two indices: the health worker motivation score (a composite of 23
items affecting motivation[19]) and the proportion of interviewed health workers who had
received job training in the preceding 12 months. The finance domain was calculated based on
availability of a financial action plan, availability of a person in charge of finance at the facility,
and whether the person in charge had received job training in the preceding 12 months. The
governance domain was assessed by a 16-item questionnaire self-administered by a team of
managers and lay workers at each facility. This tool was adapted and validated in Zambia
using methodology described elsewhere[20]. The service capacity domain comprised indices
of basic infrastructure, basic equipment, laboratory capacity, drug availability, and infection
control. The service provision domain included indices of service readiness, adult clinical
observation and pediatric clinical observation. The service readiness index was assessed by a
facility audit of availability of selected essential health services, existence of guidelines and pro-
tocols, and recent use of service registers. Clinical observation indices were based on five adult
encounters (irrespective of presenting complaint) and five pediatric encounters of children
less than five years of age presenting with fever, cough, or diarrhea.
Programmatic outcome
In the SUVA cohort, HIV-infected women and their HIV-exposed newborns (30 days of
life) were recruited at the health facility and via the community-based networks from the
BHOMA project[13]. Maternal HIV infection was confirmed through review of medical rec-
ords (e.g., antenatal card) or through on-site rapid HIV antibody testing by trained personnel.
As described previously, according to the standard of care at the time, all HIV-infected
Health systems capacity and PMTCT outcomes in Zambia
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pregnant and breastfeeding women were routinely offered lifelong antiretroviral treatment.
We collected demographic and medical information at enrollment, 6 weeks, 6 months, 12
months, and 18 months. Although the primary outcome was infant HIV infection or death, we
also collected data about maternal antiretroviral drug use, the primary outcome for the current
analysis, by asking participants: “Are you taking antiretroviral drugs now?” This information
was recorded at enrollment and each subsequent study visit. Our sample size for each site was
40 mother-infant pairs. Because of a slower-than-anticipated pace of enrollment, particularly
in rural sites, we later truncated follow-up to 12 months to increase the time for recruitment.
Ethical considerations
The University of Zambia Biomedical Research Ethics Committee (Lusaka, Zambia) and the
University of North Carolina Institutional Review Board (Chapel Hill, NC, USA) reviewed
and approved both studies. All participants were informed about the purpose of the studies
and provided written informed consent prior to taking part.
Statistical analysis
As part of the BHOMA initiative, we conducted evaluations of health systems capacity across
42 sites in Lusaka Province. All health facilities were classified as either rural or peri-urban, as
defined in the primary BHOMA study[16]. The SUVA study recruited participants from 33 of
these health facilities and surrounding communities. We restricted the health facility analysis
to the facilities for which we also had SUVA outcome data with sufficient sample size. We
excluded four additional sites because of the small number of SUVA enrollments (<10
mother-infant pairs), out of concerns around estimate precision. Therefore, the final sample
size for this secondary analysis was 29 sites. All participated in the SUVA and BHOMA
studies.
Our unit of analysis was the health facility and its surrounding community (also referred to
as the “site”). Health system capacity, our primary exposure, was evaluated using the balanced
scorecard instrument described above[16, 18]. Domain-specific scores were calculated for
patient satisfaction, human resources, finance, governance, service capacity, and service provi-
sion. We generated the overall facility score by calculating the unweighted mean of the individ-
ual indices described above. Both domain and overall facility scores could range from 0 to 100,
with higher scores indicating greater facility capacity. Median overall and domain scores were
calculated for all facilities and stratified by district. Variance in overall facility scores by district
was investigated via the Kruskal-Wallis test by ranks.
Our primary outcome was self-reported maternal antiretroviral drug use at 12 months, a
metric of health service utilization obtained from the SUVA study. We estimated an overall
proportion and site-specific proportions of maternal antiretroviral drug use. To determine the
possible association between health system capacity (primary exposure) and antiretroviral
drug use (primary outcome), we constructed linear regression models. In our analyses, we
considered the overall facility score for health systems capacity, as well as domain-specific
scores. Beta coefficients of the regression, representing the change in facility-level proportion
of maternal antiretroviral drug use per unit increase in facility capacity score, were estimated
with 95% confidence intervals and statistical significance was defined as a p value of<0.05. All
statistical analyses were performed using Stata version 14.1 (College Station, TX, USA).
Results
From June 2015 to December 2015, we evaluated health systems capacity in 42 Lusaka Prov-
ince facilities. Among the 29 facilities included in this analysis, median scores calculated for
Health systems capacity and PMTCT outcomes in Zambia
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each domain were as follows: patient satisfaction 75 (IQR 71–78), human resources 85 (IQR
63–87), finance 50 (IQR 50–67), governance 82 (IQR 74–91), service capacity 77 (IQR 68–79),
and service provision 60 (IQR 52–76). The median overall facility score was 72 (IQR 67–74;
Table 1). Overall facility scores did not appear to differ by district (p = 0.11; Fig 1a).
From June 2014 to November 2015, we enrolled HIV-infected mothers and their newborn
infants into the community cohort component of SUVA. Across the 29 sites, we enrolled a
total of 804 mother-infant pairs. The median number of mother-infant pairs enrolled at each
site was 25 (IQR 18–40; Fig 2). Retention remained high throughout the 12-month SUVA fol-
low-up period, with only 10 (1.2%) mother-infant pairs lost to follow-up or withdrawing early
from the study. The overall proportion of reported antiretroviral drug use at 12 months post-
partum was 80.7% (SD ±39.5%).
Of the six domains, only patient satisfaction was significantly associated with our primary
outcome (β = 0.22; 95%CI 0.04–0.41) in linear regression (Table 2). Other domains (i.e.,
finance, governance, service capacity, service provision) appeared to be positively associated
with maternal antiretroviral drug use; however, none reached the threshold for statistical sig-
nificance (Fig 3). Overall facility scores were not associated with reported 12-month maternal
antiretroviral drug use.
In sensitivity analysis, we generated a composite 4-domain facility score by excluding the
human resources and finance domains because of their non-normal distributions. These
4-domain facility scores—comprising patient satisfaction, governance, service capacity, and
service provision—varied significantly by district (Fig 1b) and appeared to predict higher pro-
portions of 12-month maternal antiretroviral drug use in some districts more than others (Fig
4). Composite 4-domain facility scores in Chilanga and Chongwe were positively associated
with maternal antiretroviral drug use (β = 0.24; 95%CI 0.01–0.47), while those in Kafue and
Rufunsa were not (β = 0.01; 95%CI -0.63–0.65). Similarly, facility scores in peri-urban facilities
were associated with maternal antiretroviral drug use at 12 months (β = 0.34; 95%CI 0.19–
0.48) in contrast to rural facilities (β = 0.16; 95%CI -0.11–0.43). The facilities with composite
4-domain facility scores in the lowest quartile had significantly lower proportion of maternal
antiretroviral drug use at 12 months postpartum (median 69%, IQR 63–85) compared to those
in the highest three quartiles (median 85%, IQR 71–90; p = .03).
Discussion
The delivery of universal ART to pregnant and breastfeeding women requires strong health
systems. To date, few studies have shown a relationship between health care capacity and pro-
grammatic outcomes at the site level. In this secondary analysis, we found several domain-spe-
cific scores showed positive correlation and one (patient satisfaction) met our a priori
threshold for statistical significance. While our primary analysis showed no association
between overall health system capacity and maternal ART use at 12 months postpartum, we
found heterogeneity at the district level and among peri-urban versus rural facilities. These
findings suggest that the separate components of health systems capacity—and other basic
characteristics of the health facility—may relate differently to health service utilization and
population outcomes. Understanding such relationships can help to guide the allocation of
resources for building capacity more efficiently and effectively.
We graded the capacity of health facilities using a balanced scorecard approach previously
adapted and validated by our study team[16, 21, 22]. This instrument is a mixed method evalu-
ative tool that employs interviewer- and self-administered quantitative and qualitative assess-
ments among a representative sample of observations at each facility. The components of the
scorecard are based on the WHO building blocks of health systems, a framework originally
Health systems capacity and PMTCT outcomes in Zambia
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developed to facilitate the allocation of investments in health system strengthening[17]. While
the framework itself has limitations when used to quantify system-wide intervention impact, it
remains the most universally employed and understood[23]. In our analysis, the human
resources and finance domains each adopted more discrete rather than continuous distribu-
tions, likely due to limited variation in responses. Measurement approaches that establish
broader distributions within these domains could facilitate more granular analyses and should
be considered in future work.
By leveraging data from two studies performed concurrently at the same facilities, we had
the unique opportunity to investigate associations between facility-level health system capacity
scores and community-level maternal ART utilization[16, 18]. However, the two studies were
not originally designed to complement each other and their temporal implementation did not
perfectly overlap. It is conceivable that by not directly measuring the facility capacity and out-
come simultaneously and by excluding some health facilities because of low SUVA recruit-
ment, we may have introduced error. Such limitations would more likely lead to Type II error
(i.e., failure to reject a false null hypothesis).
We chose postpartum maternal ART use as our primary outcome because it is a relatively
proximal measure of program impact. While maternal ART use is not a direct health outcome,
it is an important indicator of longitudinal follow-up in the context of universal ART and one
that corresponds strongly with maternal and infant health[5, 24]. We note other potential limi-
tations as well. As a self-reported indicator, our primary outcome may have been influenced
by reporting, recall, and social desirability biases. Although our study was implemented during
Table 1. Balanced scorecard of health facilities overall and by district (N = 29).
Facility Scores Health Facility Scores, %
Median (IQR)
All Chilanga Chongwe Kafue Rufunsa
N = 29 N = 5 N = 12 N = 9 N = 3
Overall Facility Score 72 (67–74) 78 (70–80) 72 (67–74) 73 (71–74) 65 (58–71)
Patient Satisfaction Domain 75 (71–78) 78 (77–78) 74 (69–79) 74 (73–75) 65 (60–79)
Patient satisfaction index—Children 75 (68–78) 80 (77–83) 72 (63–82) 75 (72–75) 58 (47–78)
Patient satisfaction index—Adults 75 (73–78) 75 (74–75) 75 (71–81) 75 (73–78) 73 (71–79)
Human Resources Domain 85 (63–87) 63 (62–88) 85 (83–86) 86 (62–90) 86 (84–89)
Health worker motivation score 73 (69–76) 76 (73–76) 70 (67–73) 75 (73–79) 71 (68–78)
Health worker training in past year 100 (50–100) 50 (50–100) 100 (0–100) 100 (50–100) 100 (100–100)
Finance Domain
Finance index 50 (50–67) 75 (50–75) 50 (50–58) 50 (50–67) 50 (50–75)
Governance Domain
Governance index 82 (74–91) 84 (81–93) 79 (68–85) 85 (81–93) 74 (72–90)
Service Capacity Domain 77 (68–79) 77 (77–79) 77 (69–82) 78 (76–79) 64 (51–72)
Basic infrastructure index 79 (75–83) 71 (67–79) 77 (71–83) 83 (79–83) 75 (46–75)
Basic equipment index 75 (70–95) 75 (70–95) 83 (68–98) 70 (70–90) 50 (30–80)
Laboratory capacity index 81 (63–81) 90 (63–100) 75 (65–81) 81 (63–81) 81 (38–86)
Tracer drugs index 81 (70–86) 81 (81–86) 71 (67–78) 90 (86–95) 67 (30–76)
Infection control index 72 (63–78) 67 (63–67) 78 (75–83) 56 (56–78) 67 (61–72)
Service Provision Domain 60 (52–76) 83 (78–83) 56 (48–64) 69 (58–77) 53 (34–60)
Service readiness index 75 (70–80) 85 (75–86) 75 (66–79) 73 (72–80) 76 (67–79)
Clinical observation index—Children 77 (60–84) 84 (77–85) 69 (59–80) 78 (71–95) 42 (15–84)
Clinical observation index—Adults 40 (0–60) 80 (60–80) 30 (0–40) 40 (20–80) 20 (0–60)
https://doi.org/10.1371/journal.pone.0202889.t001
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the nationwide transition to Option B+ services for PMTCT (i.e., universal ART for all preg-
nant and breastfeeding women), we were unable to verify maternal ART adherence using viral
load, drug levels, or other modalities. While various self-reported ART adherence measures
have been validated in other programmatic contexts[25–27], it is possible that residual biases
persisted. Such biases inherent to self-reported outcomes generally result in an over-estimation
of ART use and could lead to improper rejection of the null hypothesis if the biases are over-
represented among attendees at facilities with higher capacity scores. Furthermore, we cannot
confirm the generalizability of our results and specifically whether our estimate of ART use
postpartum is indicative of the larger population. By investigating a single process indicator as
our programmatic outcome, we may miss other important associations with health systems
capacity. However, because the primary outcome of the SUVA study—infant HIV-free sur-
vival—demonstrated low variability across sites, we opted to investigate the association
between facility capacity scores and an outcome with greater heterogeneity[13]. Future studies
could consider other steps in the PMTCT cascade—e.g., antepartum HIV testing, maternal
ART initiation and viral suppression, infant prophylaxis and HIV-free survival—to determine
whether health systems capacity may relate differently to other health behaviors and outcomes.
Of the six domains of health capacity evaluated, only patient satisfaction significantly pre-
dicted maternal ART use at 12 months postpartum. Several studies have shown that patient-
provider interactions and overall patient satisfaction can influence ART uptake and adherence,
retention in HIV care, and even viral suppression[28–32]. In the multi-country PEARL study,
for example, we observed a significant association between the antenatal care quality score and
PMTCT coverage. There was also a positive trend between PMTCT coverage and patient satis-
faction; however, this did not reach statistical significance (p = 0.06)[31]. A qualitative study
Fig 1. 1a. Boxplot of median overall facility score (all domains) by district, N = 29. 1b. Boxplot of median composite
facility score (4 domains) by district, N = 29.
https://doi.org/10.1371/journal.pone.0202889.g001
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among teen antenatal attendees in Limpopo Province, South Africa reported that client-coun-
selor relationship during pretest counseling was a key determinant in HIV testing, and fear of
poor treatment by care providers was a major factor in adherence to subsequent recommenda-
tions[33]. Another study found that long clinic wait times and negative interactions with
Fig 2. Participating clinics in Lusaka Province, Zambia with N representing number of mother-infant pairs enrolled at each
clinic.
https://doi.org/10.1371/journal.pone.0202889.g002
Table 2. Linear regression of reported 12-month postpartum maternal antiretroviral use by facility overall and domain scores (N = 29).
Facility Score Coefficient 95% CI p
Patient Satisfaction 0.22 (0.04,0.41) 0.02
Human Resources -0.41 (-0.94,0.12) 0.12
Finance 0.07 (-0.44,0.57) 0.78
Governance 0.18 (-0.15,0.50) 0.27
Service Capacity 0.10 (-0.16,0.36) 0.43
Service Provision 0.30 (-0.17,0.77) 0.20
Overall, all domains 0.09 (-0.10,0.28) 0.32
Composite 4 domains 0.18 (-0.03,0.40) 0.09
Chilanga + Chongwe, n = 17 0.24 (0.01,0.47) 0.04
Kafue + Rufunsa, n = 12 0.01 (-0.63,0.65) 0.97
Peri-urban facilities, n = 6 0.34 (0.19,0.48) 0.003
Rural facilities, n = 23 0.16 (-0.11,0.43) 0.28
https://doi.org/10.1371/journal.pone.0202889.t002
Health systems capacity and PMTCT outcomes in Zambia
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providers were significant barriers to antenatal ART uptake in Uganda[30]. Finally, lack of pri-
vacy in antenatal clinics—particularly as it can lead to involuntary disclosure—has been
reported as a barrier to engagement and retention in care[34, 35]. Interventions directed at
improving the patient experience in PMTCT programs could help to close gaps left by systems
and interventions focused primarily on programmatic performance and clinical outcomes[36,
37]. Health facility evaluations in this study were broadly implemented and not limited to
PMTCT programs or stakeholders. Future studies could directly investigate the relationship
between PMTCT-specific program acceptability, uptake, adherence, and retention. In addi-
tion, similar to our study, evaluations should consider both adult and children’s experiences
with care in determining the quality of health services from patients’ perspectives.
Each facility domain may contribute differently to the equitable delivery of evidence-based
interventions and towards impact along the PMTCT cascade[38, 39]. Overall facility capacity
—and systems strengthening interventions—may lead to varied effects on health outcomes
depending on underlying facility and patient characteristics. Indeed, one criticism of the
WHO framework is that individual building blocks, each independent and weighted equally,
obviate a holistic and context-specific assessment of facility or system quality[23]. These find-
ings suggest a need for further investigation of the impact of baseline health systems capacity
and strengthening interventions on PMTCT process indicators and patient-level outcomes.
The current drive to strengthen health systems should be benchmarked against appropriate
service delivery outcomes in order to demonstrate the value of such efforts and justify targeted
donor support[17].
Conclusions
Although we note positive trends between several domain and overall facility capacity scores,
patient satisfaction most strongly predicted maternal antiretroviral use at 12 months after
Fig 3. Scatter plot of reported 12-month postpartum maternal antiretroviral use by facility domain scores (N = 29).
https://doi.org/10.1371/journal.pone.0202889.g003
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delivery. The association between overall health system capacity and maternal antiretroviral
drug use was stronger in peri-urban compared to rural facilities. Our findings demonstrate the
need for an improved understanding of the facility- and participant-level factors that truly
affect PMTCT program impact and health outcomes to promote targeted investment in health
system strengthening towards these priorities.
Supporting information
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(CSV)
Fig 4. Scatter plot of reported 12-month postpartum maternal antiretroviral use by composite 4-domain facility score,
stratified by district (N = 29).
https://doi.org/10.1371/journal.pone.0202889.g004
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